10-dihydroanthracene, and myristoyljuglone. All compounds were used in pure form for the bioassays. Of the 17 test compounds four showed notable tumor-promoting activity. They are 1,8-dihydroxy-10-acetyl-9-anthrone, 1,8-dihydroxy-10-myristoyl-9-anthrone, 1-hydroxy-9-anthrone, and juglone. In order to determine whether there is any relationship between tumor-promoting activity and metal chelation in this series
在单次应用亚致癌剂量的7,12-二甲基苯并[
蒽]
蒽后,通过使用雌性ICR / Ha Swiss小鼠在小鼠皮肤上重复皮肤应用,测试了肿瘤
促进剂anthralin的17种类似物的相同
生物学特性。测试的化合物中有七个是新化合物。它们是1,8-
二乙酰氧基-9-
蒽酮,1,8-二肉豆蔻酰氧基-9-
蒽酮,1,8-二羟基-10-乙酰基-9-
蒽酮,1,8-二羟基-10-肉豆蔻酰基-9-
蒽酮, 1,8,10-三羟基-9-
蒽酮,
1,8-二羟基-9,10-二氢蒽和肉豆蔻酰juglone。所有化合物均以纯净形式用于
生物测定。在17种测试化合物中,有4种显示出明显的促肿瘤活性。它们是1,8-二羟基-10-乙酰基-9-
蒽酮,1,8-二羟基-10-肉豆蔻酰基-9-
蒽酮,1-羟基-9-
蒽酮和juglone。为了确定在该系列中促进肿瘤的活性与
金属螯合之间是否存在任何关系,使用二价
金属离子Cu(II),Zn()检测了
蒽林及其非活性类似物1